Geode Capital Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $7.64K | Hold |
|
|||||
|
2024
Q1 | $60.5K | Buy |
|
|||||
|
2023
Q4 | $40.8K | Sell |
|
|||||
|
2023
Q3 | $223K | Buy |
|
|||||
|
2023
Q2 | $1.39M | Buy |
|
|||||
|
2023
Q1 | $787K | Buy |
|
|||||
|
2022
Q4 | $757K | Buy |
|
|||||
|
2022
Q3 | $1.14M | Buy |
|
|||||
|
2022
Q2 | $681K | Sell |
|
|||||
|
2022
Q1 | $1.35M | Buy |
|
|||||
|
2021
Q4 | $2.58M | Sell |
|
|||||
|
2021
Q3 | $4.15M | Buy |
|
|||||
|
2021
Q2 | $3.59M | Buy |
|
|||||
|
2021
Q1 | $2.71M | Buy |
|
|||||
|
2020
Q4 | $492K | Buy |
|
|||||
|
2020
Q3 | $144K | Hold |
|
|||||
|
2020
Q2 | $155K | Hold |
|
|||||
|
2020
Q1 | $75K | Hold |
|
|||||
|
2019
Q4 | $206K | Hold |
|
|||||
|
2019
Q3 | $141K | Hold |
|
|||||
|
2019
Q2 | $336K | Buy |
|
|||||
|
2019
Q1 | $129K | Buy |
|
|||||
|
2018
Q4 | $43K | Hold |
|
|||||
|
2018
Q3 | $70K | Hold |
|
|||||
|
2018
Q2 | $89K | Buy |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Hold |
|
|||||
|
2015
Q3 | – | Hold |
|
|||||
|
2015
Q2 | – | Hold |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Hold |
|
|||||
|
2014
Q3 | – | Hold |
|
|||||
|
2014
Q2 | – | Hold |
|
|||||
|
2014
Q1 | – | Hold |
|
|||||
|
2013
Q4 | – | Hold |
|
|||||
|
2013
Q3 | – | Hold |
|
|||||
|
2013
Q2 | – | Hold |
|